Cost-Containment

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019.

The industry is reaching a tipping point where an increasingly loud chorus of voices are demanding transparency and a focus on health strategy.

State officials threatened to withhold public money from hospitals, pioneering a strategy that could become a national model.

ERIC notes that its own employer members have been fiduciaries for decades.

The insurer, once a major player in medical insurance, is going in as some carriers are complaining about high claim costs.

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.

The revision includes the new coverage affordability percentage.

The employers told Mercer plan changes should hold their spending increases to 5.8%, in a new survey.